<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04196192</url>
  </required_header>
  <id_info>
    <org_study_id>QIP10/12/19HJ</org_study_id>
    <nct_id>NCT04196192</nct_id>
  </id_info>
  <brief_title>Febrile Infants - Diagnostic Assessment and Outcome</brief_title>
  <acronym>FIDO</acronym>
  <official_title>Febrile Infants - Diagnostic Assessment and Outcome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Belfast Health and Social Care Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bristol Royal Hospital for Children</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospitals, Leicester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Barts &amp; The London NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Belfast Health and Social Care Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess how clinicians apply national UK guidance in the
      assessment of febrile infants presenting the the Emergency Department. The measurable
      outcomes are:

      Primary Objective Compliance with current National Institute for Health and Clinical
      Excellence Guidance (Feverish Illness in the Under 5s)

      Report the rates of serious and invasive bacterial infections in febrile infants

      Secondary Objectives Report on the predictive value of different clinical features for
      predicting bacterial infections.

      Report on the value of biomarkers for predicting serious and invasive bacterial infections.

      Assess the performance of other clinical practice guidelines for the assessment of febrile
      infants.

      Complete a cost evaluation to report the cost of current care per patient
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The assessment of febrile infants is difficult. In the UK current guidance advocates that
      most children under 3 months of age with a fever undergo a full septic screen including
      lumbar puncture and receive parenteral antibiotics. Approaches in the United States and
      Europe including the Rochester and StepByStep approach allow for the discharge home of some
      low risk young infants.

      We intend to assess the current approach to febrile infants and compare that to the national
      standard. We also intend to retrospectively assess if alternate approaches (e.g. Rochester)
      could have been safely applied to that population and to determine which clinical and/or
      laboratory features are most predictive of serious/invasive bacterial infection.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2020</start_date>
  <completion_date type="Anticipated">September 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Invasive bacterial infection</measure>
    <time_frame>seven days</time_frame>
    <description>Invasive Bacterial Infection (non-contaminant) confirmed by culture or molecular diagnostic testing of a sterile site i.e. blood or cerebrospinal fluid (CSF). Staphylococcus epidermidis, Propionibacterium acnes, Streptococcus viridans, or Diphtheroides were considered contaminants.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serious bacterial infections</measure>
    <time_frame>seven days</time_frame>
    <description>Urinary tract infections defined as growth of â‰¥100 000 cfu/mL Bacterial gastroenteritis (isolation of bacteria in stool culture). Pneumonia (confirmed by consultant radiologist report of chest radiograph) Cellulitis diagnosed clinically</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Sepsis</condition>
  <condition>Meningitis, Bacterial</condition>
  <condition>Bacterial Infections</condition>
  <condition>Viral Infection</condition>
  <condition>Urinary Tract Infections</condition>
  <condition>Pneumonia</condition>
  <condition>Gastroenteritis</condition>
  <condition>Cellulitis</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>All infants aged 0-90 days (inclusive) undergoing routine assessments for fever without source.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Procalcitonin Blood Testing</intervention_name>
    <description>None beyond usual care</description>
    <arm_group_label>Group 1</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Infants aged 0-90 days (inclusive) with a fever of 38 degrees centigrade or higher recorded
        on arrival to hospital between the 01/09/2018 and the 31/08/2019. Conducted across four
        sites in the UK (all large tertiary children's hospitals).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any infant aged 0 to 90 days (inclusive) with a fever of 38 degrees centigrade or
             higher recorded on arrival to hospital.

        Exclusion Criteria:

          -  Clear focus for infection on initial assessment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>90 Days</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Thomas Waterfield</last_name>
    <phone>+447872990521</phone>
    <email>thomas.waterfield@googlemail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Royal Belfast Hospital for Sick Children</name>
      <address>
        <city>Belfast</city>
        <state>Northern Ireland</state>
        <zip>BT126BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Waterfield</last_name>
      <phone>02890633755</phone>
      <email>twaterfield01@qub.ac.uk</email>
    </contact>
    <contact_backup>
      <last_name>Michael Shields</last_name>
      <phone>02890633755</phone>
      <email>m.shields@qub.ac.uk</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Bristol Royal Children's Hospital</name>
      <address>
        <city>Bristol</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Lyttle</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Leicester Royal Infirmary</name>
      <address>
        <city>Leicester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Damian Roland</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal London Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Becky Platt</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>December 10, 2019</study_first_submitted>
  <study_first_submitted_qc>December 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 12, 2019</study_first_posted>
  <last_update_submitted>July 9, 2020</last_update_submitted>
  <last_update_submitted_qc>July 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Belfast Health and Social Care Trust</investigator_affiliation>
    <investigator_full_name>Thomas Waterfield</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Urinary Tract Infections</mesh_term>
    <mesh_term>Bacterial Infections</mesh_term>
    <mesh_term>Cellulitis</mesh_term>
    <mesh_term>Meningitis, Bacterial</mesh_term>
    <mesh_term>Gastroenteritis</mesh_term>
    <mesh_term>Meningitis</mesh_term>
    <mesh_term>Virus Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Anonymised datasets not containing any personal data will be available after publication</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

